The Blood Transfusion Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Blood Transfusion Diagnostics Market?
The market size of the Blood Transfusion Diagnostics Global Market Report 2025 has seen a fast-paced growth in recent years. The market which was worth $4.42 billion in 2024 is anticipated to grow to $4.96 billion in 2025. This growth will occur at a compound annual growth rate (CAGR) of 12.2%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Blood Transfusion Diagnostics Industry?
The Blood Transfusion Diagnostics market is projected to reach a size of $6.43 billion in 2029, with a compound annual growth rate (CAGR) of 6.7%.
Download Your Free Sample of the 2025 Blood Transfusion Diagnostics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Blood Transfusion Diagnostics Market?
The key drivers in the blood transfusion diagnostics market are:
• Rising demand for precision medicine
• Growing investments in blood transfusion infrastructure
• Increasing demand for molecular blood transfusions
• Emergence of new infectious diseases and concerns over blood safety
Global Market Segmentation: Identifying Major Blood Transfusion Diagnostics Industry Segments
The blood transfusion diagnostics market covered in this report is segmented –
1) By Type: Instruments and Kits, Reagents, Other Types
2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test
3) By Application: Blood Grouping, Disease Screening
4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies
Pre-order the 2025 Blood Transfusion Diagnostics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Blood Transfusion Diagnostics Market?
The key trends in the blood transfusion diagnostics market are:
• There is a trend toward advancements in diagnostic technology in the blood transfusion market.
• The adoption of point-of-care testing, automation, and robotics is shaping the future of the market.
• The integration of digital technology and nucleic acid testing (NAT) is an emerging trend in the market.
• There is a rising trend toward expanded pathogen panels and sophisticated testing technology in the blood transfusion diagnostics market.
Who Are the Top Competitors & Leading Players in the Blood Transfusion Diagnostics Market?
Major companies in the blood transfusion diagnostics market are:
• BAG Health Care GmbH
• Grifols S.A.
• Bio-Rad Laboratories Inc.
• Abbott Laboratories
• Immucor Inc.
• Ortho Clinical Diagnostics
• DiaSorin S.p.A
• Siemens Healthineers
• Thermo Fisher Scientific Inc.
• Beckman Coulter Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd.
• bioMerieux
• Diagast SAS
• Fujirebio
• Biokit S.A.
• QuidelOrtho Corporation
• Danaher Corporation
• Becton Dickinson and Company
• Quotient Biodiagnostics
• Sekisui Diagnostics
• Sysmex Corporation
• Werfen S.A.
Regional Dominance: Which Area Leads the Global Blood Transfusion Diagnostics Market?
The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada
